Clinical Trial Detail

NCT ID NCT02381548
Title Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)

chronic myeloid leukemia

acute myeloid leukemia

bone marrow cancer


Adavosertib + Belinostat

Age Groups: adult

Additional content available in CKB BOOST